United States
Germany
Japan
United Kingdom
China
Anti-HP mouse monoclonal antibody, clone OTI4H5 (formerly 4H5)
| Applications | FC, IF, WB |
| Reactivities | Human |
Antibodies
LGALS3BP mouse monoclonal antibody, clone OTI3D6 (formerly 3D6)
| Applications | FC, IF, IHC, WB |
| Reactivities | Human |
CD163 mouse monoclonal antibody, clone OTI2B12 (formerly 2B12)
| Applications | IF, IHC, LMNX, WB |
| Reactivities | Human |
RAB37 mouse monoclonal antibody, clone OTI2F1 (formerly 2F1)
| Applications | IF, IHC, WB |
| Reactivities | Human, Mouse, Rat |
MUC1 (EMA) mouse monoclonal antibody, clone OTI3A7 (formerly 3A7)
| Applications | IF, IHC, WB |
| Reactivities | Human |
CD163 mouse monoclonal antibody, clone OTI2F8 (formerly 2F8)
| Applications | IF, IHC, WB |
| Reactivities | Human |
TA506388 is a possible alternative to AM21062PU-N.
LIPG mouse monoclonal antibody, clone OTI3C7 (formerly 3C7)
| Applications | FC, IF, IHC, IP, WB |
| Reactivities | Human |
CNY 1,999.00
CNY 2,700.00
现货
TGFB1 mouse monoclonal antibody, clone OTI1E12 (formerly 1E12)
| Applications | FC, IF, WB |
| Reactivities | Human, Mouse, Rat |
TNF mouse monoclonal antibody, clone OTI1C1 (formerly 1C1)
| Applications | FC, IF, WB |
| Reactivities | Human |
LIPG mouse monoclonal antibody, clone OTI6E11 (formerly 6E11)
| Applications | FC, IF, IHC, IP, WB |
| Reactivities | Human |
CNY 1,999.00
CNY 2,700.00
现货
F13A1 (Factor XIIIa) mouse monoclonal antibody, clone OTI1H2 (formerly 1H2)
| Applications | IF, IHC, WB |
| Reactivities | Human, Mouse, Rat |
活动过滤器
优化搜索结果
Category
Target Symbol
Reactivities
Clonalities
Pathways
- Pathways in cancer (24)
- MAPK signaling pathway (21)
- Cytokine-cytokine receptor interaction (18)
- Glycerolipid metabolism (12)
- Hypertrophic cardiomyopathy (HCM) (12)
- Metabolic pathways (12)
- Regulation of actin cytoskeleton (12)
- Dilated cardiomyopathy (9)
- Endocytosis (9)
- Jak-STAT signaling pathway (9)
- Prostate cancer (9)
- TGF-beta signaling pathway (9)
- Cell cycle (6)
- Chronic myeloid leukemia (6)
- Colorectal cancer (6)
- Graft-versus-host disease (6)
- Hematopoietic cell lineage (6)
- NOD-like receptor signaling pathway (6)
- Neuroactive ligand-receptor interaction (6)
- Pancreatic cancer (6)
- Renal cell carcinoma (6)
- Toll-like receptor signaling pathway (6)
- Adipocytokine signaling pathway (3)
- Allograft rejection (3)
- Alzheimer's disease (3)
- Amyotrophic lateral sclerosis (ALS) (3)
- Apoptosis (3)
- Asthma (3)
- Basal cell carcinoma (3)
- Complement and coagulation cascades (3)
- Cytosolic DNA-sensing pathway (3)
- Fc epsilon RI signaling pathway (3)
- Hedgehog signaling pathway (3)
- Melanoma (3)
- Natural killer cell mediated cytotoxicity (3)
- Prion diseases (3)
- RIG-I-like receptor signaling pathway (3)
- SNARE interactions in vesicular transport (3)
- Systemic lupus erythematosus (3)
- T cell receptor signaling pathway (3)
- Type I diabetes mellitus (3)
- Type II diabetes mellitus (3)
